Vancouver, British Columbia--(Newsfile Corp. - April 1, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") today announced a non-brokered private placement of up to $1,172,600 CAD. The proceeds will be used to acquire up to 410 Ethereum(ETH) tokens to support the Company's expanding on-chain infrastructure initiatives.

Under the terms of the offering, Beyond Medical will issue up to 9,020,000 common shares at a price of $0.13 per share. The securities will be subject to a statutory hold period of four months and one day from the date of issuance. The offering remains subject to approval by the Canadian Securities Exchange (CSE).

The Company may pay finder's fees to eligible finders in connection with the offering, subject to compliance with applicable securities laws and CSE policies.

The ETH acquired will be allocated toward enhancing Beyond Medical's blockchain-based healthcare attestation platform, including funding for transaction fees, smart contract deployment, node operation, and other decentralized services. As previously disclosed, operating an Ethereum node is critical to the platform's performance, enabling secure data interactions without reliance on third-party infrastructure or rate limits.

In conjunction with the offering, the Company is also announcing the launch of Republic, its newly formed Ethereum-backed treasury division. Republic will serve as Beyond Medical's dedicated unit for managing ETH reserves and on-chain infrastructure, with a mandate focused on security, transparency, and regulatory compliance. Modeled after leading institutional digital asset strategies, Republic is designed to provide long-term operational flexibility and financial resilience in an increasingly digitized environment.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

About Beyond Medical Technologies Inc.

Beyond Medical Technologies Inc. is a healthcare technology company integrating blockchain infrastructure to enhance patient outcomes and operational efficiency across the medical ecosystem.

On behalf of the Board of Directors

Daniel Liu, Chief Executive Officer

Email: danzliu94@gmail.com

https://beyond-md.co/

FORWARD-LOOKING STATEMENTS

This press release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable securities legislation (collectively, "forward-looking statements"). The forwardlooking statements herein are made as of the date of this press release only, and the Company does not assume any obligation to update or revise them to reflect new information, estimates or opinions, future events or results or otherwise, except as required by applicable law. Often, but not always, forwardlooking statements can be identified by the use of words such as "plans", "expects", "is expected", "budgets", "scheduled", "estimates", "forecasts", "predicts", "projects", "intends", "targets", "aims", "anticipates" or "believes" or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. These forward-looking statements include, among other things, statements relating to: the completion of the offering, the terms of the offering, the anticipated use of proceeds of the offering, the allocation of ETH towards enhancing the Company's blockchain-based healthcare attestation platform and the launch of Republic.

Such forward-looking statements are based on a number of assumptions of management, including, without limitation, that the Company will complete the offering on the terms and conditions expected, that the Company will receive all necessary approvals for the offering, that the Company will use the proceeds of the offering as currently anticipated, that the Company will allocated the ETH as currently anticipated, and the launch of Republic. Additionally, forward-looking statements involve a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of the Company to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forwardlooking statements. Such risks include, without limitation: that the Company will not receive all necessary approvals for the completion of the offering, that the Company will fail to complete the offering on the terms disclosed, or at all, that the Company will not use the proceeds of the offering as currently anticipated, that the Company will not allocate the EHT as anticipated, or at all, market volatility, the state of the financial markets for the Company's securities, and political, legal and regulatory risks generally.

The forward-looking statements contained in this press release represent management's best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this press release. Neither the Company nor any of its representatives shall have any liability whatsoever, under contract, tort, trust or otherwise, to you or any person resulting from the use of the information in this press release by you or any of your representatives or for omissions from the information in this press release.